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PROVIDERS’ AND KEY OPINION LEADERS’ ATTITUDES, BELIEFS,
AND PRACTICES CONCERNING EMERGENCY CONTRACEPTION:
A MULTICOUNTRY STUDY IN INDIA, NIGERIA, AND SENEGAL
By Martha Brady, M.E. Khan, Babatunde Ahonsi, Babacar Mané, Ian Askew, and Saumya RamaRao

Improving knowledge of and access to
reproductive health technologies is critical to improving women’s health. While
major gains have been made over the
past several decades, barriers to access
remain in many places of the world. Contraceptive technologies that enhance
women’s ability to exercise control over
their reproductive lives are particularly
important; emergency contraception is
one such example.
Emergency contraception (EC) has been in use
for more than 30 years, is available in many
countries, exists in multiple formulations, and is
offered through a range of service delivery points.
EC is an effective and safe method of preventing
pregnancy, and its provision of postcoital protection gives it a unique role in the contraceptive mix
within family planning programs.
Currently, three types of emergency contraception exist: (1) dedicated emergency contraceptive
pill (ECP) products, including levonorgestrel-only
pills and ulipristal acetate; (2) conventional oral
contraceptive pills taken in a specific timing and
dosage sequence (known as the Yuzpe method);
and (3) the insertion of a copper intrauterine device (IUD). The IUD has not been used to any
extent as EC in the developing world at this point.

BACKGROUND
Dedicated ECP products are registered in countries throughout the world, and many countries
have more than one registered ECP product. More
than 60 countries provide ECP through pharmacies. The Yuzpe method is used in settings where
no dedicated ECP products are available, and/or
where economic and service barriers prohibit
women from obtaining them. Although this type of
off-label use of oral contraceptives is an important
option for women, a dedicated product—one that
is packaged and labeled specifically for emergency
contraceptive use and made available through a
range of outlets (clinics, pharmacies, hospitals,
women’s shelters, workplaces)—could potentially
improve access and use. In theory ECP is widely
available; in practice, however, procurement, financing, and distribution mechanisms for dedicated ECP commodities are not well established in
many settings, thereby limiting availability and
resulting in an underutilized option for pregnancy
prevention.

BARRIERS TO ACCESS FOR WOMEN: POLICIES, PROVIDERS, AND HEALTH SYSTEMS
Research indicates a number of influences on
women’s access to ECP. Access is most severely
affected in countries where contextual and systems-level barriers converge to restrict provision
and use of ECP. The following barriers have been
noted across diverse settings: (1) lack of favorable
government policy; (2) misinformed policymakers

and providers; (3) undefined and inadequate service
delivery systems; and (4) stringent prescription requirements. Further, awareness of emergency contraception
and the sources of supply for ECP is limited among
potential users.

medicine vendors and local pharmacists constitute 39
percent and 10 percent, respectively, of the private
sources. Younger unmarried women tend to patronize
the private sector, whereas older married women typically obtain products through the public sector.

Role of providers and key opinion leaders
Although women’s access to ECP is constrained by many
factors, providers and key opinion leaders (KOLs) play a
key role in ensuring its availability and enhancing access
to the product. Providers’ lack of accurate information
and training in ECP, coupled with negative attitudes and
misconceptions about the method, directly affect their
provision practices and, in turn, women’s access. Key
opinion leaders, who include a range of influential individuals (e.g., senior Ministry of Health officials, leaders of
medical and pharmacy associations, civil society representatives, religious and other social leaders, donors,
etc.), also play a critical role in shaping public opinion
and influencing policy.

Senegal
In Senegal, ECP is included in the national family planning program and, in principle, is available for free at
public sector facilities. In practice, however, clients purchase ECP at pharmacies at higher prices. ECP provision in the public sector is hampered by a weak health
system characterized by poor services, poorly trained
providers, intermittent commodity supplies, and poor
recordkeeping and data monitoring.

WIDENING THE LENS AND DEEPENING THE FOCUS
ON PROVIDERS AND KEY OPINION LEADERS
Recognizing the critical role these two stakeholder
groups play in fostering or impeding access, the Population Council conducted a cross-sectional, descriptive,
multicountry study in India, Nigeria, and Senegal
aimed at understanding the attitudes, beliefs, and
practices of providers and key opinion leaders regarding the provision and use of EC. This study represents
the first systematic inquiry of KOLs in these three
countries, which have considerably different social and
policy environments.
India
In India, ECP is included in the National Family Planning
Program and, theoretically, is available at government
health and family planning facilities. Because many doctors and paramedics have not been trained, however,
uptake is low, particularly in rural areas. The product is
available over the counter, and has been aggressively
promoted in urban areas. Although the MOHFW officially
supports universal access to ECP, in practice it has not
taken action to support this policy. At the state level,
knowledge about ECP is uniformly poor and negative.
Nigeria
Although modern methods of contraception and emergency contraceptives are available over the counter, use
of modern contraceptive methods, including ECP, remains low in Nigeria. The main access point for users of
modern contraceptives is the private sector (61 percent),
compared with 23 percent in the public sector. Patent

STUDY OBJECTIVE
The overarching goal of this study was to investigate
and document providers’ attitudes, beliefs, and practices regarding ECP, and to capture the opinions and insights of providers and KOLs on a range of policy and
program issues. In addition, the study sought to experiment with question-asking regarding the concept of ―repeat use.‖

METHODOLOGY
A mix of quantitative and qualitative methods was used.
Through a quantitative survey applied to a representative sample of service providers in each country, the
study gathered information on providers’ attitudes toward ECP use and users, their level of knowledge and
training, their opinions regarding repeat use, and their
ECP provision practices. ―Provider‖ was broadly defined
to include frontline health workers, midwives, nurses,
doctors, pharmacists, patent medicine vendors, and
other health staff. Qualitative data gathered through indepth interviews with selected KOLs were combined
with provider surveys to give a robust and nuanced picture of the current situation regarding provision of ECP.
Site and sample selection
The study was designed to align with broader urban
health initiatives currently underway in each country;
thus, urban centers were selected for sampling. The
study was conducted in a total of ten urban centers: five
in India (Agra, Aligarh, Delhi, Kanpur, and Lucknow), two
in Nigeria (Abuja and Kaduna), and three in Senegal
(Dakar, Mbour, and Thies).
Using existing sampling frames in each country, a representative sample of providers was drawn from each
country. The analysis includes only providers who were
currently or had ever provided ECP.

TABLE 1 Number of interviews conducted, by provider type,
according to country
Provider type

India

Nigeria

Senegal

Total

Doctors

83

21

10

114

Paramedics

33

0

0

33

0

118

85

203

199

146

26

371

Nurse/midwife
Pharmacists
Pharmacy counter staff

0

0

30

30

Patent medicine vendors

0

122

0

122

Others
Total

0

0

4

4

315

407

155

877

Providers’ attitudes are mixed concerning provision
of ECP to particular populations (e.g., young unmarried women) and in certain contexts.
Providers and KOLs are generally not supportive of
―advance provision‖ of ECP, because of the underlying assumption that this leads to ―abuse‖ or ―over
use‖; they express concern that women will bypass
or abandon ―regular contraception‖ if ECP provision
is lenient.
The majority of providers are unsupportive of ―repeat
use‖ and/or ―regular use.‖
Interpretations and definitions of ―repeat use,‖ ―regular use,‖ and ―frequent use‖ vary widely; most providers are unable to provide a precise definition.
KOLs express some caveats about how and where
ECP should be distributed, who should provide it,
and for which target populations.

Sixty-six in-depth interviews were conducted across the
three countries with purposively sampled KOLs from
both the public and private sectors. The interviews capture multiple perspectives that reflect policy, program,
service delivery, and civil society positions.
TABLE 2
country

Number of interviews, by type of KOL, according to

Profile of
key opinion leaders
Government officials/
decisionmakers at policy
and program levels

India
8

Nigeria
4

Senegal
11

Total
23

Members of professional
associations

7

5

5

17

NGO representatives

0

3

Development partners/donors

3

1

Manufacturer

1

0

0

1

Private practitioner

0

0

1

1

Distributors

0

0

3

3

Members of communitybased organizations

0

0

7

7

19

13

34

66

Total

As shown in Table 3, the vast majority of providers in
the three countries (86–94 percent) consider ECP to
be safe, and the majority (60–82 percent) believes
TABLE 3 Percentage of providers expressing various attitudes and beliefs concerning ECP
ECP attitude/belief

India

Nigeria

Senegal

86

94

88

82

66

60

55

67

17

ECP should be available OTC without prescription

50

33

41

There should be no age
restriction on ECP

14

14

45

Frequency of use
There is no maximum number of
times a women can use EC in one
year

64

23

39

In one menstrual cycle, EC can be
used after unprotected sex as
needed

15

18

16

There should be guidance/
advice on the frequency of EC
provision for women

44

90

83

Rape or sexual coercion

15

50

93

Infrequent or unpredictable sex

55

20

81

Unprotected sex

23

49

88

3

55

54

Married women

67

12

53

Unmarried adolescents

42

14

65

(315)

(407)

(155)

Safety
3
4

FINDINGS
Each country has unique and specific findings which are
reported elsewhere (see India, Nigeria, and Senegal
briefs). Here we describe overall study results. Although
the three countries have vastly different social and political contexts, and are at different stages in the evolution of
ECP programming and maturity of family planning programs, the following key themes emerged across sites:
Gaps exist in providers’ knowledge of technical issues,
including mechanisms of action, efficacy, and timing of
use.
Wide variation across and within countries exists in
levels of training on ECP among different cadres of
providers.
KOLs hold positive views of ECP overall, believing it
fills an important niche in the contraceptive method
mix.

6

ECP is safe to use

8

Efficacy
ECP is very effective in preventing
pregnancy
Access
Women should be provided with
ECP in advance of unprotected sex

Acceptable contexts for use

Refugee or conflict settings
Acceptable users

N

that it is effective in preventing pregnancies. With regard
to more specific access issues—advance provision, age
restrictions, frequency of use—responses become more
conservative, and also vary more widely across the three
countries. The concept of ―repeat use‖ is one such divisive issue, in part, perhaps, because of the lack of standardization regarding what is meant by the term. For
some providers, the threshold for ―repeat use‖ is two or
three times per menstrual cycle, whereas for others it is
one or two times per year.

PROGRAM AND POLICY IMPLICATIONS
The identification and amelioration of provider-related
barriers is a critical avenue to improve EC access within
country programs and globally. Many provider-related
barriers can be overcome through implementation of
targeted interventions such as training and values clarification, whereas other barriers will require a broader
strategy to address contextual and health systems-level
factors that hinder women’s access to ECP.
Interventions that might prove useful in addressing
these barriers include:
Improving knowledge about ECP among providers and potential users through a variety of
channels, including digital and electronic
communication, mass media, public aware-

ness campaigns, and educational print materials for providers and potential users.
Evidence-based advocacy targeted to policymakers and donors to garner commitment
to both the concept of emergency contraception as well as ECP products, including their
integration into family planning programs,
processes, and budgets.
Efforts to reduce the cost of EC products and
product delivery. This may include bulk purchasing of commodities, greater competition
in the marketplace (with new post coital
contraceptive products), and/or negotiation
with manufacturers and distributors regarding pricing strategies.
Operational research on a range of service
delivery issues, including bridging ECP with
other family planning methods.
Social science research to better understand
the social determinants of demand and use
dynamics.
Support for research and development for
post-coital prevention products.
For more information, contact
mbrady@popcouncil.org.
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